The toxicity of adjuvants is assessed through a combination of preclinical studies and clinical trials. Preclinical studies involve testing on animals to evaluate potential toxic effects and mechanisms of action. Clinical trials further assess safety and efficacy in humans. Additionally, computational approaches and in vitro methods are increasingly used to predict potential toxicity and reduce reliance on animal testing.
